Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment

Abstract

Monitoring levels of EGFR mutation in plasma allows resolving doubts that frequently arise in daily clinical practice and constitutes a major step towards achieving personalized medicine.